It’s par for the course.all you’re missing is realistic DD and acceptance of the facts. HEMPINC has been around for ten years, just reading all the PR’s that never came to fruition shows the real story here. IMO it’s not realistic to expect a run like in 2014 with the SEC case still active and the OTC Markets refusal to allow filings.